Sort
25,944 grants matching “neurodegeneration”
TDP-43 Loss-of-Function: Biology to Biomarkers
$520,177William W Seeley · University Of California, San Francisco · P01 · FY2025 · AG
RNA-based regulation of TDP-43 nuclear export in ALS/FTD
$520,142Lindsey Renae Hayes · Johns Hopkins University · R01 · FY2021 · NS
A transcription factor complex specifically induced in neurodegeneration
$520,140Ulrich Hengst · Columbia University Health Sciences · R01 · FY2021 · NS
RNA-based regulation of TDP-43 nuclear export in ALS/FTD
$520,087Lindsey Renae Hayes · Johns Hopkins University · R01 · FY2023 · NS
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity (EXEC-study)
$520,026Ulf G Bronas · University Of Illinois At Chicago · R01 · FY2023 · AG
Protection from pathological tau by activation of the ER unfolded protein response
$520,000Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2021 · AG
Protection from pathological tau by activation of the ER unfolded protein response
$520,000Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2022 · AG
Protection from pathological tau by activation of the ER unfolded protein response
$520,000Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2023 · AG
Examining the role of brain sodium content in multiplesclerosis using MRI
$519,901Fred D Lublin · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
Mechanisms of LRRK2 Mediated Neurotoxicity
$519,765Andrew B West · Duke University · R01 · FY2024 · NS
Evolving CRISPR-based platforms for the discovery of Alzheimer relevant neurodegenerative pathways
$519,750Lennart Mucke · J. David Gladstone Institutes · R21 · FY2020 · AG
Function and Pathogenic Mechanism of alpha-synuclein in Parkinson's Disease
$519,678Huaibin Cai · National Institute On Aging · ZIA · FY2019 · AG
Use of C. elegans as a model to study aging-associated neurodegeneration
$519,671Dong Yan · Duke University · R01 · FY2023 · AG
Use of C. elegans as a model to study aging-associated neurodegeneration
$519,671Dong Yan · Duke University · R01 · FY2022 · AG
Temporal control of mitochondrial mutagenesis
$519,553Marc Vermulst · University Of Southern California · R01 · FY2023 · AG
eMB: Mouth to Mind: Leveraging network dynamical systems and software to understand diet, diabetes, dementia and modifiable risk factors delaying Alzheimer's disease
$519,526Travis B Thompson · Texas Tech University · · FY2023 · MPS
Oxidative Stress, Immune Activation, and Therapeutic Targeting in HIV/HAND
$519,471Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2015 · MH
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
$519,465Yulin Ge · New York University School Of Medicine · R01 · FY2013 · NS
In vivo characterization of the PET pharmacokinetic properties of T807 in humans
$519,384Julie C. Price · Massachusetts General Hospital · R01 · FY2017 · AG
Polyglutamine conformation and neurodegeneration
$519,214Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2006 · NS
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION
$519,208Bruce A Yankner · Harvard Medical School · P01 · FY2008 · AG
Development of an Agonist of the TGF-beta Signaling Pthway to Treat Alzheimer's
$519,203Tony Wyss-Coray · Palo Alto Veterans Instit For Research · U01 · FY2011 · NS
Development of an Agonist of the TGF-beta Signaling Pathway to Treat Alzheimer's
$519,203Tony Wyss-Coray · Palo Alto Veterans Instit For Research · U01 · FY2011 · NS
Ameliorating Respiratory Neuromotor Dysfunctions in Aging and Alzheimer's Disease
$519,054Matthew Fogarty · Mayo Clinic Rochester · R01 · FY2024 · AG
Dendrite regulation by the mitochondrial kinase PINK1: Implications for PD/LBD
$518,935Charleen T Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · NS